Across TCGA pan-cancer cohorts, RNVU1-18 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RNVU1-18’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where RNVU1-18 RNA is repressed in tumor relative to normal tissue. In most cancer types RNVU1-18 is over-expressed in tumor, although a few such as THCA and BRCA show the opposite, repressed pattern.

THCA and BRCA are the cancer types where RNVU1-18 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNVU1-18 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	All	−0.839	<.001	10	view →
BRCA	All	III,IV	−0.105	.049	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RNVU1-18 RNA expression & survival · all RNVU1-18 data types